Most of us who have any interest in business have by now heard of a company called Theranos. About 2005 onwards, Theranos claimed to have a revolutionary blood testing technology that could do over 200 types of tests from a single drop of blood.
The company was valued at over $10 billion and was widely considered to be at the vanguard of a complete disruption of medical technology by Silicon Valley startups. Traditional medical testing leaders
. Read more on economictimes.indiatimes.com